Jad Chahoud

Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, open-label, phase 3 trial

Sumanta K. Pal, Laurence Albigès, Piotr Tomczak et al. · The Lancet · 2023 · 173 citations · Full text

Urology, Genitourinary Cancer, Medicine +7

Effective combinatorial immunotherapy for penile squamous cell carcinoma

Tianhe Huang, Xi Cheng, Jad Chahoud et al. · Nature Communications · 2020 · 75 citations · Full text

Whole-exome Sequencing in Penile Squamous Cell Carcinoma Uncovers Novel Prognostic Categorization and Drug Targets Similar to Head and Neck Squamous Cell Carcinoma

Jad Chahoud, Frederico O. Gleber‐Netto, Barrett Z. McCormick et al. · Clinical Cancer Research · 2021 · 66 citations · Full text

Pembrolizumab for advanced penile cancer: a case series from a phase II basket trial

Andrew W. Hahn, Jad Chahoud, Matthew T. Campbell et al. · Investigational New Drugs · 2021 · 54 citations

Urology, Genitourinary Cancer, Medicine +5

Real-World Survival Outcomes Associated With First-Line Immunotherapy, Targeted Therapy, and Combination Therapy for Metastatic Clear Cell Renal Cell Carcinoma

Nicholas H. Chakiryan, Da David Jiang, Kyle Gillis et al. · JAMA Network Open · 2021 · 49 citations · Full text